Shelter Pharma Complete Financial Statements
SHELTER • Review detailed financials to uncover trends, confirm thesis & journal trades
7 Years of Data
2025 - 2017
Complete Financial Data Export
Export complete financial statements for Shelter Pharma (SHELTER).
Downloads include all available records across all periods.
For market performance, see the
SHELTER stock price today
.
Profitability Ratios
Net Profit Margin
13.73%
2025 data
EBITDA Margin
19.61%
2025 data
Operating Margin
20.00%
2025 data
Return on Assets
14.58%
2025 data
Return on Equity
16.28%
2025 data
Balance Sheet Ratios
Current Ratio
33.00
2025 data
Debt to Equity
1.12
2025 data
Equity Ratio
89.58%
2025 data
Asset Turnover
1.06
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+26.3%
Year-over-Year
Equity Growth
+19.4%
Year-over-Year
Liabilities Growth
+26.3%
Year-over-Year
Operating Cash Flow Growth
+400.0%
Year-over-Year
Investing Cash Flow Growth
-75.0%
Year-over-Year
Financing Cash Flow Growth
-100.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 51 | 40 | 36 | 30 | 23 | 30 |
| Expenses | 0 | 41 | 32 | 28 | 27 | 22 | 30 |
| EBITDA | 0 | 10 | 9 | 8 | 3 | 0 | 0 |
| Operating Profit Margin % | 0.00% | 20.00% | 21.00% | 22.00% | 10.00% | 1.00% | 1.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 10 | 8 | 7 | 3 | 0 | 0 |
| Tax | 0 | 2 | 2 | 2 | 1 | 0 | 0 |
| Net Profit | 0 | 7 | 6 | 5 | 2 | 0 | 0 |
| Earnings Per Share (₹) | 0.00 | 6.26 | 5.36 | 6.72 | 42.54 | 0.88 | 1.77 |
Related Pages for Shelter Pharma
Additional stock information and data for SHELTER
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Total Assets | 48 | 38 | 21 | 13 | 10 | 11 |
| Current Assets | 33 | 30 | 19 | 10 | 8 | 8 |
| Fixed Assets | 6 | 4 | 2 | 2 | 2 | 2 |
| Capital Work in Progress | 0 | 0 | 0 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 42 | 34 | 20 | 11 | 9 | 9 |
| LIABILITIES | ||||||
| Total Liabilities | 48 | 38 | 21 | 13 | 10 | 11 |
| Current Liabilities | 1 | 1 | 1 | 0 | 0 | 0 |
| Non-Current Liabilities | ||||||
| SHAREHOLDERS' EQUITY | ||||||
| Total Equity | 43 | 36 | 15 | 9 | 7 | 7 |
| Share Capital | 12 | 12 | 8 | 1 | 1 | 1 |
| Reserves & Surplus | 31 | 24 | 7 | 8 | 7 | 7 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2017 |
|---|---|---|---|---|---|---|---|
| Operating Activities | 6 | -2 | 0 | 1 | 0 | 0 | 0 |
| Investing Activities | -7 | -4 | 0 | -1 | 0 | 0 | 0 |
| Financing Activities | 0 | 11 | 0 | 0 | 1 | 0 | 0 |
| Net Cash Flow | -2 | 5 | 0 | 0 | 0 | 0 | 0 |